---
title: "Hologic Extends CEO Stephen MacMillan’s Employment Agreement"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/258147123.md"
description: "Hologic, Inc. has extended CEO Stephen MacMillan's employment agreement, emphasizing stable leadership and strategic direction. The latest analyst rating for Hologic (HOLX) is a Hold with a $72.00 price target. Spark's AI Analyst rates HOLX as Neutral, noting strong revenue growth but highlighting the need for improved profitability and cash flow. The company's market cap is $15.17B, with a positive outlook despite high valuation concerns."
datetime: "2025-09-19T20:37:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258147123.md)
  - [en](https://longbridge.com/en/news/258147123.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258147123.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/258147123.md) | [繁體中文](https://longbridge.com/zh-HK/news/258147123.md)


# Hologic Extends CEO Stephen MacMillan’s Employment Agreement

The latest announcement is out from Hologic ( (HOLX) ).

On September 18, 2025, Hologic, Inc. announced an amendment to the employment agreement with its CEO, Stephen P. MacMillan, extending the term of the agreement. This extension reflects the company’s commitment to stable leadership, potentially impacting its strategic direction and reassuring stakeholders of continued executive oversight.

The most recent analyst rating on (HOLX) stock is a Hold with a $72.00 price target. To see the full list of analyst forecasts on Hologic stock, see the HOLX Stock Forecast page.

**Spark’s Take on HOLX Stock**

According to Spark, TipRanks’ AI Analyst, HOLX is a Neutral.

Hologic’s overall stock score reflects a stable financial position with strong revenue growth, though profitability and cash flow growth need improvement. The positive sentiment from the earnings call and strategic initiatives provide a favorable outlook. However, the high valuation and mixed technical indicators suggest caution.

To see Spark’s full report on HOLX stock, click here.

**More about Hologic**

Hologic, Inc. operates in the medical technology industry, focusing on developing and providing diagnostic products, medical imaging systems, and surgical products, primarily for women’s health.

**Average Trading Volume:** 1,961,614

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $15.17B

Learn more about HOLX stock on TipRanks’ Stock Analysis page.

### 相关股票

- [Hologic (HOLX.US)](https://longbridge.com/zh-CN/quote/HOLX.US.md)

## 相关资讯与研究

- [Retirement Systems of Alabama Decreases Stock Holdings in Hologic, Inc. $HOLX](https://longbridge.com/zh-CN/news/281340112.md)
- [Becker Capital Management Inc. Boosts Holdings in Hologic, Inc. $HOLX](https://longbridge.com/zh-CN/news/277596016.md)
- [18:07 ETImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors](https://longbridge.com/zh-CN/news/276953964.md)
- [Readystate Asset Management LP Buys New Stake in Hologic, Inc. $HOLX](https://longbridge.com/zh-CN/news/276208974.md)
- [BTIG Reaffirms Their Hold Rating on Hologic (HOLX)](https://longbridge.com/zh-CN/news/276485663.md)